Literature DB >> 8843758

Effect of a glucokinase inhibitor on energy production and insulin release in pancreatic islets.

I R Sweet1, G Li, H Najafi, D Berner, F M Matschinsky.   

Abstract

Glucokinase has exclusively high control strength on glucose usage in the pancreatic beta-cell. However, glucokinase also has extraordinarily high control strength on insulin secretion, which is linked to the phosphate potential, [ATP]/([ADP][Pi]) (F.M. Matschinsky, Y.Liang, P. Kesavan, L. Wang, P. Froguel, G. Velho, D. Cohen, M.A. Permutt, Y. Tanizawa, T.L. Jetton, K. Niswender, and M.A. Magnuson. J. Clin. Invest. 92: 2092-2098, 1993). We propose that the ATP produced via the tricarboxylic acid cycle is approximately constant, irrespective of the glucose level. Furthermore, the component of ATP production that is derived from glycolysis and glycolytically derived NADH, which is shuttled into the mitochondria, is a critical signal controlling the ionic events leading to insulin secretion, as suggested previously (M. J. MacDonald. Diabetes 39: 1461-1466, 1990 and I.D. Dukes, M.S. McIntyre, R.J. Mertz, L.H. Philipson, M.W. Roe, B. Spencer, and J.F. Worley III. J. Biol. Chem. 269: 10979-10982, 1994). To test this hypothesis, glucose usage, oxidation, and insulin secretion were measured in cultured rat islets over a wide range of concentrations of glucose and mannoheptulose, an inhibitor of glucokinase. These data were fit to a mathematical model that predicts that glucokinase will govern the rate of glucose usage and ATP production and will also have a strong, but not complete, control over the rate of glucose oxidation, the phosphate potential, and insulin release. Mannoheptulose caused an inhibition of all three fluxes. The estimates of the mechanistic parameters of the model [maximal velocity (Vmax) and Michaelis constant for glucokinase, Vmax for hexokinase and glucose transport, and the inhibition constant of mannoheptulose to glucokinase] were similar to those obtained in vitro. Thus the data are consistent with a model in which the primary importance of glycolysis in transducing the glucose signal into changes of the phosphate potential imparts to glucokinase a high control strength on glucose-induced insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843758     DOI: 10.1152/ajpendo.1996.271.3.E606

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

1.  Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics.

Authors:  Nicolai M Doliba; Wei Qin; Habiba Najafi; Chengyang Liu; Carol W Buettger; Johanna Sotiris; Heather W Collins; Changhong Li; Charles A Stanley; David F Wilson; Joseph Grimsby; Ramakanth Sarabu; Ali Naji; Franz M Matschinsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-27       Impact factor: 4.310

2.  Glucose modulates [Ca2+]i oscillations in pancreatic islets via ionic and glycolytic mechanisms.

Authors:  Craig S Nunemaker; Richard Bertram; Arthur Sherman; Krasimira Tsaneva-Atanasova; Camille R Daniel; Leslie S Satin
Journal:  Biophys J       Date:  2006-06-30       Impact factor: 4.033

3.  Reduced cytochrome C is an essential regulator of sustained insulin secretion by pancreatic islets.

Authors:  Seung-Ryoung Jung; Iok Teng Denise Kuok; Drew Couron; Norma Rizzo; Daciana H Margineantu; David M Hockenbery; Francis Kim; Ian R Sweet
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

4.  Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency.

Authors:  Preeti Tandon; Catherine A Gallo; Shikha Khatri; Jennifer F Barger; Hasmik Yepiskoposyan; David R Plas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

5.  Reducing Glucokinase Activity Restores Endogenous Pulsatility and Enhances Insulin Secretion in Islets From db/db Mice.

Authors:  Ishrat Jahan; Kathryn L Corbin; Avery M Bogart; Nicholas B Whitticar; Christopher D Waters; Cara Schildmeyer; Nicholas W Vann; Hannah L West; Nathan C Law; Jeffrey S Wiseman; Craig S Nunemaker
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

6.  Control of insulin secretion by cytochrome C and calcium signaling in islets with impaired metabolism.

Authors:  Austin M Rountree; Adam S Neal; Mark Lisowski; Norma Rizzo; Jared Radtke; Sarah White; Dan S Luciani; Francis Kim; Christiane S Hampe; Ian R Sweet
Journal:  J Biol Chem       Date:  2014-05-19       Impact factor: 5.157

7.  A self referencing platinum nanoparticle decorated enzyme-based microbiosensor for real time measurement of physiological glucose transport.

Authors:  E S McLamore; J Shi; D Jaroch; J C Claussen; A Uchida; Y Jiang; W Zhang; S S Donkin; M K Banks; K K Buhman; D Teegarden; J L Rickus; D M Porterfield
Journal:  Biosens Bioelectron       Date:  2010-09-29       Impact factor: 10.618

Review 8.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Nanomaterial based self-referencing microbiosensors for cell and tissue physiology research.

Authors:  Jin Shi; Eric S McLamore; D Marshall Porterfield
Journal:  Biosens Bioelectron       Date:  2012-07-17       Impact factor: 10.618

10.  Dysregulation of glucose homeostasis in nicotinamide nucleotide transhydrogenase knockout mice is independent of uncoupling protein 2.

Authors:  Nadeene Parker; Antonio J Vidal-Puig; Vian Azzu; Martin D Brand
Journal:  Biochim Biophys Acta       Date:  2009-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.